Richard I Steinhart Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard I Steinhart.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard I Steinhart. Richard I Steinhart is Director in TG THERAPEUTICS, INC. ($TGTX) and Director in Actinium Pharmaceuticals, Inc. ($CTVN) and Director in ATOSSA GENETICS INC ($ATOS) and Chief Financial Officer in BioXcel Therapeutics, Inc. ($BTAI).
Latest Insider Trading Transactions of Richard I Steinhart
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ATNM, ATOS, BTAI, TGTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 29 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 41.17 | 20,000 | 823,400 | 20,000 | |
| Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | M | 5.55 | 3,750 | 20,813 | 80,148 | |
| Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Sell | S | 48.15 | 3,750 | 180,563 | 1,500 | 5.3 K to 1.5 K (-71.43 %) |
| Feb 03 2021 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | M | 5.55 | 3,750 | 20,813 | 5,250 | 1.5 K to 5.3 K (+250.00 %) |
| Aug 14 2020 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 9.55 | 8,333 | 79,580 | 8,333 | |
| May 28 2020 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 45.99 | 55,000 | 2,529,450 | 55,000 | |
| May 19 2020 | ATOS | ATOSSA THERAPEUTIC ... | Steinhart Richard I | Director | Option Exercise | A | 1.70 | 45,000 | 76,500 | 45,000 | |
| Jul 16 2019 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 0.23 | 250,000 | 58,000 | 250,000 | |
| May 21 2019 | ATOS | ATOSSA GENETICS IN ... | Steinhart Richard I | Director | Option Exercise | A | 2.52 | 45,000 | 113,400 | 45,000 | |
| Dec 04 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | P | 5.20 | 500 | 2,600 | 1,500 | 1,000 to 1.5 K (+50.00 %) |
| Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | P | 5.00 | 500 | 2,500 | 1,000 | 500 to 1,000 (+100.00 %) |
| Nov 30 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Buy | P | 5.00 | 500 | 2,500 | 500 | 0 to 500 |
| Jul 17 2018 | ATNM | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 0.78 | 75,000 | 58,718 | 75,000 | |
| Jun 29 2018 | ATOS | ATOSSA GENETICS IN ... | Steinhart Richard I | Director | Option Exercise | A | 2.38 | 45,000 | 107,100 | 45,000 | |
| Mar 13 2018 | BTAI | BioXcel Therapeuti ... | Steinhart Richard I | Chief Financial Off ... | Option Exercise | A | 11.00 | 32,232 | 354,552 | 116,130 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | J | 0.70 | 5,250 | 3,675 | 5,250 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | J | 0.60 | 1,750 | 1,050 | 1,750 | |
| Mar 08 2018 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Buy | J | 0.50 | 7,000 | 3,500 | 9,500 | 2.5 K to 9.5 K (+280.00 %) |
| May 26 2017 | ATOS | ATOSSA GENETICS IN ... | Steinhart Richard I | Director | Option Exercise | A | 0.47 | 49,531 | 23,280 | 59,062 | |
| Mar 16 2017 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 1.39 | 75,000 | 104,250 | 75,000 | |
| May 19 2016 | ATOS | ATOSSA GENETICS IN ... | Steinhart Richard I | Director | Option Exercise | A | 0.26 | 71,484 | 18,800 | 71,484 | |
| Apr 18 2016 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 1.99 | 75,000 | 149,250 | 75,000 | |
| Apr 18 2016 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Buy | P | 2.01 | 2,500 | 5,025 | 2,500 | 0 to 2.5 K |
| May 14 2015 | ATOS | ATOSSA GENETICS IN ... | Steinhart Richard I | Director | Option Exercise | A | 1.37 | 40,000 | 54,800 | 40,000 | |
| Mar 16 2015 | CTVN | Actinium Pharmaceu ... | Steinhart Richard I | Director | Option Exercise | A | 3.58 | 25,000 | 89,500 | 25,000 | |
| Feb 22 2005 | TGTX | TG THERAPEUTICS, I ... | Steinhart Richard I | Director | Option Exercise | A | 1.00 | 11,010 | 11,010 | 11,010 | |
| Sep 28 2004 | TGTX | TG THERAPEUTICS, I ... | Steinhart Richard I | Director | Option Exercise | A | 0.97 | 80,000 | 77,600 | 80,000 |
Page: 1